The goal of the Digestive Disease Epidemiology Training Program at the University of North Carolina is to train independent researchers who will improve our understanding of the magnitude, etiology and impact of digestive diseases, and who will assume leadership roles in GI epidemiology and outcomes research. To accomplish that mission, the program includes a comprehensive curriculum with the following features: 1) formal advanced training in epidemiologic methods and biostatistics;2) a 2 - 3 year period of training culminating in an MPH, MSCR or PhD in epidemiology;3) emphasis on design, execution, analysis and publication of a research project;4) mentors to guide the developing investigator;5) an integrative core curriculum designed to develop additional skills necessary for an academic career;6) concurrent training of MD and PhD candidates in a program that ranges from molecular epidemiology to population-based health outcomes research;7) a training advisory committee with diverse membership to encourage breadth of vision by the trainees. The training program is designed to support one-pre-doctoral and three post-doctoral candidates each year. The program takes advantage of unique and considerable institutional strengths in public health and gastroenterology. A stable, diverse, and multidisciplinary faculty provides trainees expert guidance in epidemiology, biostatistics, and health outcomes research. The training faculty of 17 includes 16 members of the adult and pediatric GI Divisions of whom 11 have advanced training in epidemiology or biostatistics. The active research programs of the training faculty are well funded from federal sources. Prior trainees in this program have remarkable records of publication and success in obtaining faculty positions on completion of the fellowship.
Digestive diseases have a major impact on health in the United States. The proposed Digestive Disease Epidemiology Training Program will develop independent researchers who will improve our understanding of the magnitude, etiology and impact of digestive diseases, and who will assume leadership roles in GI epidemiology and outcomes research.
|Murphy, Caitlin C; Sandler, Robert S; Grubber, Janet M et al. (2016) Underuse and Overuse of Colonoscopy for Repeat Screening and Surveillance in the Veterans Health Administration. Clin Gastroenterol Hepatol 14:436-444.e1|
|Wolf, W Asher; Piazza, Nicholas A; Gebhart, Jessica H et al. (2016) Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis. Dig Dis Sci :|
|Dellon, Evan S; Cotton, Cary C; Gebhart, Jessica H et al. (2016) Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol 14:31-9|
|Kochar, Bharati; Aldridge, Molly; Cook, Suzanne Follan et al. (2016) Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease. J Med Internet Res 18:e124|
|Runge, Thomas M; Eluri, Swathi; Cotton, Cary C et al. (2016) Causes and Outcomes of Esophageal Perforation in Eosinophilic Esophagitis. J Clin Gastroenterol :|
|Pasricha, Sarina; Gupta, Amit; Reed, Craig C et al. (2016) Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia. Dig Dis Sci 61:2935-41|
|Cotton, Cary C; Erim, Daniel; Eluri, Swathi et al. (2016) Cost Utility Analysis of Topical Steroids Compared to Dietary Elimination for Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol :|
|Wright, Benjamin L; Kulis, Mike; Guo, Rishu et al. (2016) Food-specific IgG4 is associated with eosinophilic esophagitis. J Allergy Clin Immunol 138:1190-1192.e3|
|Cotton, Cary C; Baird, Donna; Sandler, Robert S et al. (2016) Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis. Inflamm Bowel Dis 22:1631-8|
|Eluri, Swathi; Runge, Thomas M; Cotton, Cary C et al. (2016) The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc 83:1142-8|
Showing the most recent 10 out of 179 publications